Nutrition and Mental Health Research Group (NUTRISAM), Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), 43201 Tarragona, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), 43005 Tarragona, Spain.
J Clin Endocrinol Metab. 2024 Feb 20;109(3):730-739. doi: 10.1210/clinem/dgad594.
Little is known about whether parity is associated with elevated early-pregnancy insulin resistance (IR), or whether overweight/obesity contributes to increasing the possible effect.
We determined the associations between parity and glucose metabolism parameters in the first trimester of pregnancy in a Mediterranean pregnant population, and whether these associations are affected by overweight/obesity.
A cross-sectional study was conducted of 264 healthy pregnant women from the ECLIPSES study who were recruited at 12 weeks of gestation. At baseline, details on socioeconomic status, obstetric history (including parity, ie, number of births), lifestyle factors, anthropometry, and blood samples were collected. Fasting serum glucose, insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) index were assessed in the first trimester. Elevated IR was defined as the upper HOMA-IR tertile (≥1.58). Multivariable linear regression and Cox regression model with constant time were performed.
Parity ranged from 0 to 4. After multivariable adjustment, the insulin levels (β [% change]: 20.92; 95% CI, 4.08-37.71) and HOMA-IR index (β [% change]: 19.72; 95% CI, 2.43-40.49) were positively associated with parity. Additionally, multiparous women, as compared to nulliparous, were more likely to have higher HOMA-IR levels (primiparous [1 birth], β [% change[: 16.88; 95% CI, -1.00 to 37.99; multiparous [≥2 births), β [% change]: 32.18; 95% CI, 3.56-68.71), and an increased relative risk (RR) of an elevated IR (primiparous [1 birth], RR: 1.55; 95% CI, 1.03-2.36; multiparous (≥2 births), RR: 1.72; 95% CI, 1.05-2.83). The combination of multiparity and overweight/obesity conferred a 3.04-fold increase in the RR of elevated IR, which increased proportionally to the number of parities.
This study demonstrates that parity may have a negative effect on early-pregnancy IR and that maternal overweight/obesity appears to further aggravate this relationship.
关于初产妇是否与早期妊娠胰岛素抵抗(IR)升高有关,或者超重/肥胖是否会增加这种可能性,目前知之甚少。
我们旨在确定地中海孕妇人群中初产妇与妊娠 12 周时糖代谢参数之间的关联,以及这些关联是否受超重/肥胖的影响。
对 ECLIPSES 研究中的 264 名健康孕妇进行了一项横断面研究,这些孕妇在妊娠 12 周时被招募。在基线时,收集了社会经济状况、产科史(包括产次,即分娩次数)、生活方式因素、人体测量学和血液样本等详细信息。在妊娠早期评估空腹血清葡萄糖、胰岛素和稳态模型评估的胰岛素抵抗(HOMA-IR)指数。将胰岛素抵抗升高定义为上 HOMA-IR 三分位数(≥1.58)。进行了多变量线性回归和具有常数时间的 Cox 回归模型。
产次范围为 0 至 4。经过多变量调整后,胰岛素水平(β[百分比变化]:20.92;95%置信区间,4.08-37.71)和 HOMA-IR 指数(β[百分比变化]:19.72;95%置信区间,2.43-40.49)与产次呈正相关。此外,与初产妇相比,多产妇更有可能出现更高的 HOMA-IR 水平(初产妇[1 次分娩],β[百分比变化]:16.88;95%置信区间,-1.00 至 37.99;多产妇[≥2 次分娩],β[百分比变化]:32.18;95%置信区间,3.56-68.71),并且发生胰岛素抵抗升高的相对风险(RR)增加(初产妇[1 次分娩],RR:1.55;95%置信区间,1.03-2.36;多产妇[≥2 次分娩],RR:1.72;95%置信区间,1.05-2.83)。多产和超重/肥胖的组合使发生胰岛素抵抗升高的 RR 增加了 3.04 倍,且随着产次的增加而呈比例增加。
本研究表明,产次可能对妊娠早期的胰岛素抵抗产生负面影响,而母亲超重/肥胖似乎进一步加重了这种关系。